Release of chemoattractants for human monocytes from endothelial cells by interaction with neutrophils

Cardiovascular Research

Volumn 38, Issue 2, 1998, Pages 516-521

  Schratzberger, Peter ^a   Dunzendorfer, Stefan ^a   Reinisch, Norbert ^a   Kähler, Christian M ^a   Herold, Manfred ^a   Wiedermann, Christian J ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Endothelium; Granulocyte; Human; Monocyte; Monocyte chemoattractant protein 1

Indexed keywords

CD14 ANTIGEN; CYCLOHEXIMIDE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1;

ARTICLE; CELL INTERACTION; CHEMOTAXIS; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MONOCYTE; MONOLAYER CULTURE; NEUTROPHIL; PRIORITY JOURNAL; SUPERNATANT; UMBILICAL VEIN;

ARTERIOSCLEROSIS; CELL COMMUNICATION; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOTAXIS, LEUKOCYTE; COCULTURE TECHNIQUES; CYCLOHEXIMIDE; ENDOTHELIUM, VASCULAR; HUMANS; LEUKOCYTES, MONONUCLEAR; NEUTROPHILS; PROTEIN SYNTHESIS INHIBITORS; TIME FACTORS;

EID: 0032076221     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00014-5     Document Type: Article

References (32)

1. [1] Prescott MF, McBride CK, Court M. Development of intimal lesions after leukocyte migration into the vascular wall. Am J Pathol 1989;135:835-846.
2. [2] Betz E, Schlote W. Responses of vessel walls to chronically applied electrical stimuli. Basic Res Cardiol 1979;74:10-20.
3. [3] Bochner BS, Luscinskas FW, Gimbrone MA, et al. Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med 1991;173:1553-1557.
4. [4] Kling D, Holzschuh T, Betz E. Recruitment and dynamics of leukocytes in the formation of arterial intimal thickening: a comparative study with normo-and hypercholesterinemic rabbits. Atherosclerosis 1993;101:79-96.
5. [5] Kling D, Holzschuh T, Betz E. Temporal sequence of morphological alterations in artery walls during experimental atherogenesis: occurrence of leukocytes. Res Exp Med (Berl) 1987;187:237-250.
6. [6] Kling D, Fingerle J, Harlan JM. Inhibition of leukocyte extravasation with a monoclonal antibody to CD18 during formation of experimental intimal thickening in rabbit carotid arteries. Arterioscler Thromb 1992;12:997-1007.
7. [7] Kling D, Fingerle J, Harlan JM, Lobb RR, Lang F. Mononuclear leukocytes invade rabbit arterial intima during thickening formation via CD18-and VLA-4-dependent mechanisms and stimulate smooth muscle migration. Circ Res 1995;77:1121-1128.
8. [8] Sugiyama S, Kugiyama K, Ohgushi M, Fujimoto K, Yasue H. Lysophosphatidylcholine in oxidized low-density lipoprotein increases endothelial susceptibility to polymorphonuclear leukocyte-induced endothelial dysfunction in porcine coronary arteries. Circ Res 1994;74:565-575.
9. [9] Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-809.
10. [10] Libby P, Hansson GK. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest 1991;64:5-15.
11. [11] Wiedermann CJ, Wiedermann FJ, Apperl A, et al. In vitro human polymorphonuclear chemokinesis and human monocyte chemotaxis are different activities of amino-terminal and carboxy-terminal substance P. Naunyn-Schmiedeberg's Arch Pharmacol 1989;340:185-191.
12. [12] Dunzendorfer S, Rothbucher D, Schratzberger P, et al. Mevalonate-dependent inhibition of transendothelial migration and chemotaxis of human peripheral blood neutrophils by pravastatin. Circ Res 1997;81:963-970.
13. [13] Dunzendorfer S, Schratzberger P, Reinisch N, Kähler CM, Wiedermann CJ. Effects of thalidomide on neutrophil respiratory burst, chemotaxis, and transmigration of cytokine-and endotoxin-activated endothelium. Naunyn-Schmiedeberg's Arch Pharmacol 1997;356:529-535.
14. [14] Wiedermann CJ, Schratzberger P, Kähler CM. Migration of neutrophils across endothelial monolayers is stimulated by treatment of the monolayers with β-endorphin. Brain Behav Immun 1994;8:270-277.
15. [15] Wilkinson PC. Micropore filter methods for leukocyte chemotaxis. Methods Enzymol 1988;162:38-50.
16. [16] Takahashi M, Masuyama JI, Ikeda U, et al. Induction of monocyte chemoattractant protein-1 synthesis in human monocytes during transendothelial migration in vitro. Circ Res 1995;76:750-757.
17. [17] van Damme J, Proost P, Put W, et al. Induction of monocyte chemotactic proteins MCP-1 and MCP-2 in human fibroblasts and leukocytes by cytokines and cytokine inducers. J Immunol 1994;152:5495-5502.
18. [18] Weiss SJ. Tissue destruction by neutrophils. New Engl J Med 1989;320:365-376.
19. [19] van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994;89:36-44.
20. [20] Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 1986;6:131-138.
21. [21] Kloner RA, Giacomelli F, Alker KJ, et al. Influx of neutrophils into the walls of large epicardial coronary arteries in response to ischemia/reperfusion. Circulation 1991;84:1758-1772.
22. [22] Moser R, Schleiffenbaum B, Groscurth P, Fehr J. Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage. J Clin Invest 1989;83:444-455.
23. [23] Watson RWG, Rotstein OD, Nathens AB, Parodo J, Marshall JC. Neutrophil apoptosis is modulated by endothelial transmigration and adhesion molecule engagement. J Immunol 1997;158:945-953.
24. [24] Daniak N, Sorba S. Intracellular regulation of the production and release of human erythroid-directed lymphokines. J Clin Invest 1991;87:213-220.
25. [25] Totani L, Piccoli A, Pellegrini G, Di Santo A, Lorenzet R. Polymorphonuclear leukocytes enhance release of growth factors by cultured endothelial cells. Arterioscler Thromb 1994;14:125-132.
26. [26] Zeiher AM. Endothelial vasodilator dysfunction: pathogenetic link to myocardial ischemia or epiphenomenon?. Lancet 1996;348(suppl I):10-12.
27. [27] Libby P. Atheroma: more than mush. Lancet 1996;348(suppl I):4-7.
28. [28] Nelken NA, Coughlin SR, Gordon D, Wilcox JN. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 1991;88:1121-1217.
29. [29] Rollins BJ, Yoshimura T, Leonhard EJ, Pober JS. Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. Am J Pathol 1990;136:1229-1233.
30. [30] Navab M, Hama SY, Lenten BJV, et al. Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest 1991;88:2039-2046.
31. [31] Fuhlbrigge RC, Chaplin DD, Kiely J-M, Unanue ER. Regulation of interleukin-1 gene expression is selectively regulated by adherence and lipopolysaccharide. J Immunol 1987;138:3799-3802.
32. [32] Eierman DF, Johnson CE, Haskill JS. Human monocyte inflammatory mediator gene expression is selectively regulated by adherence substrates. J Immunol 1989;142:1970-1976.